Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment
Baird Medical (NASDAQ: BDMD) sponsored an advanced Microwave Ablation (MWA) training session in New Orleans, focusing on thyroid treatment. The session was led by Dr. Emad Kandil from Tulane University School of Medicine, with participation from Dr. Salem Noureldine of George Washington University. Dr. Noureldine observed five live MWA cases and practiced advanced techniques.
Dr. Kandil, who has performed over 80 MWA procedures, recently presented at the American Thyroid Association meeting, highlighting MWA's effectiveness compared to Radiofrequency Ablation. The training emphasized MWA's efficiency and patient-centered design, notably the absence of grounding pads. Dr. Noureldine received a Certificate of Completion, preparing him to integrate MWA into clinical practice.
Baird Medical (NASDAQ: BDMD) ha sponsorizzato una sessione avanzata di formazione sull'Ablazione a Microonde (MWA) a New Orleans, focalizzandosi sul trattamento della tiroide. La sessione è stata guidata dal Dr. Emad Kandil della Tulane University School of Medicine, con la partecipazione del Dr. Salem Noureldine della George Washington University. Il Dr. Noureldine ha osservato cinque casi dal vivo di MWA e ha praticato tecniche avanzate.
Il Dr. Kandil, che ha effettuato oltre 80 procedure di MWA, ha recentemente presentato all'incontro dell'American Thyroid Association, sottolineando l'efficacia della MWA rispetto all'Ablazione a Radiofrequenza. La formazione ha enfatizzato l'efficienza della MWA e il design incentrato sul paziente, in particolare l'assenza di panni di messa a terra. Il Dr. Noureldine ha ricevuto un Certificato di Completamento, preparandosi ad integrare la MWA nella pratica clinica.
Baird Medical (NASDAQ: BDMD) patrocinó una sesión avanzada de formación en Ablación por Microondas (MWA) en Nueva Orleans, enfocándose en el tratamiento de la tiroides. La sesión fue dirigida por el Dr. Emad Kandil de la Escuela de Medicina de la Universidad de Tulane, con la participación del Dr. Salem Noureldine de la Universidad George Washington. El Dr. Noureldine observó cinco casos en vivo de MWA y practicó técnicas avanzadas.
El Dr. Kandil, quien ha realizado más de 80 procedimientos de MWA, presentó recientemente en la reunión de la Asociación Americana de Tiroides, destacando la efectividad de la MWA en comparación con la Ablación por Radiofrecuencia. La capacitación enfatizó la eficiencia de la MWA y su diseño centrado en el paciente, especialmente la ausencia de almohadillas de aterrizaje. El Dr. Noureldine recibió un Certificado de Finalización, preparándose para integrar la MWA en la práctica clínica.
Baird Medical (NASDAQ: BDMD)는 뉴올리언스에서 갑상선 치료에 중점을 둔 고급 마이크로파 아블레이션(MWA) 교육 세션을 주최했습니다. 이 세션은 튤레인 대학교 의과대학의 Dr. Emad Kandil이 이끌었으며, 조지워싱턴 대학교의 Dr. Salem Noureldine이 참여했습니다. Noureldine 박사는 MWA 사례 다섯 건을 관찰하고 고급 기술을 연습했습니다.
80건 이상의 MWA 시술을 수행한 Kandil 박사는 최근 미국 갑상선 학회에서 발표하며 MWA의 효과성을 라디오파 아블레이션과 비교했습니다. 교육은 MWA의 효율성과 환자 중심 설계를 강조했으며, 특히 접지 패드의 부재에 대해 논의했습니다. Noureldine 박사는 이수증을 받아 MWA를 임상 실무에 통합할 준비를 했습니다.
Baird Medical (NASDAQ: BDMD) a sponsorisé une session de formation avancée sur l'Ablation par Micro-ondes (MWA) à La Nouvelle-Orléans, axée sur le traitement de la thyroïde. La session était dirigée par le Dr Emad Kandil de l'École de Médecine de l'Université de Tulane, avec la participation du Dr Salem Noureldine de l'Université George Washington. Le Dr Noureldine a observé cinq cas en direct de MWA et a pratiqué des techniques avancées.
Le Dr Kandil, qui a réalisé plus de 80 procédures de MWA, a récemment présenté lors de la réunion de l'American Thyroid Association, soulignant l'efficacité de la MWA par rapport à l'Ablation par Radiofréquence. La formation a mis l'accent sur l'efficacité de la MWA et son design centré sur le patient, notamment l'absence de coussinets de mise à la terre. Le Dr Noureldine a reçu un Certificat de Complétion, le préparant à intégrer la MWA dans la pratique clinique.
Baird Medical (NASDAQ: BDMD) sponsorte eine fortgeschrittene Schulung zur Mikrowellenablation (MWA) in New Orleans mit Schwerpunkt auf der Behandlung der Schilddrüse. Die Sitzung wurde von Dr. Emad Kandil von der Tulane University School of Medicine geleitet, mit Teilnahme von Dr. Salem Noureldine von der George Washington University. Dr. Noureldine beobachtete fünf Live-Fälle von MWA und übte fortgeschrittene Techniken.
Dr. Kandil, der über 80 MWA-Verfahren durchgeführt hat, präsentierte kürzlich auf dem Treffen der American Thyroid Association und hob die Wirksamkeit der MWA im Vergleich zur Radiofrequenzablation hervor. Die Schulung betonte die Effizienz der MWA und das patientenzentrierte Design, insbesondere die Abwesenheit von Erdungspads. Dr. Noureldine erhielt ein Abschlusszertifikat, um sich auf die Integration der MWA in die klinische Praxis vorzubereiten.
- Company is actively expanding its MWA technology adoption through physician training programs
- Key opinion leader Dr. Kandil has performed over 80 MWA procedures, validating the technology's clinical adoption
- Technology demonstrates competitive advantages over RFA, including simpler procedure without grounding pads
- None.
The session, led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, featured participation from Dr. Salem Noureldine, Assistant Professor of Surgery and Associate Program Director at George Washington University. Dr. Noureldine observed five MWA live cases, practiced advanced techniques with the equipment, and explored the distinctive features of this innovative therapy. He noted the quickness and efficiency of MWA during procedures, with the absence of grounding pads emphasizing the simplicity and patient-centered design of the technique.
Dr. Kandil, who has performed over 80 MWA procedures, recently presented at the American Thyroid Association (ATA) annual meeting. He highlighted MWA's effectiveness compared to Radiofrequency Ablation (RFA) and shared clinical insights, stating, "MWA of thyroid nodules is a novel, safe, and effective method for treating appropriately selected patients."
Dr. Noureldine also engaged in meaningful post-training discussions with Dr. Kandil, gaining further insights into the transformative potential of MWA. He received a Certificate of Completion, marking his enhanced proficiency and readiness to integrate MWA into clinical practice.
"Expanding access to groundbreaking therapies like MWA begins with equipping physicians with the skills and knowledge they need to succeed," said Haimei Wu, Chairwoman of Baird Medical. "By investing in training programs led by experts such as Dr. Kandil, we aim to foster collaboration and ensure more patients can benefit from advanced thyroid care."
Baird Medical is dedicated to supporting clinicians through specialized training programs. These initiatives aim to bridge advanced technology with expert knowledge, promoting broader access to minimally invasive solutions in thyroid care.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-sponsored-microwave-ablation-training-enhances-thyroid-treatment-302338080.html
SOURCE BDMD
FAQ
What was the outcome of BDMD's recent MWA training session in New Orleans?
How many MWA procedures has Dr. Kandil performed with BDMD's technology?
What advantages does BDMD's MWA technology offer over Radiofrequency Ablation?
Where did Dr. Kandil present BDMD's MWA clinical insights?
